≥2 ARMS/GROUPS: DICHOTOMOUS OUTCOMES (e.g. OR, RR, %death)

UI Author Year Outcome Exposure Categories(e.g., Tertiles)/Intervention Groups Mean Vit D level/dose Ca intake No. of Cases (Event) * Person years Mean Follow-up, mo Crude or Adjusted analysis? Outcome Metric (e.g. OR, RR, HR, %) Outcome effect size CI P between groups *** P for trend ****
8621198 Ascherio 1996 Hypertension Ca intake
category 1
<400 87 5,581 14 y Adjusted RR 1.0 -- -- 0.76
category 2 400-599 608 36,605 1.07 0.85, 1.35 NS
category 3 600-799 712 42,544 1.05 0.83, 1.31 NS
category 4 800-1000 407 24,240 1.03 0.82, 1.31 NS
category 5 ≥1000 712 41,325 1.04 0.83, 1.31 NS

Duplicate one row per exposure category or intervention group.

*

Number of subjects with outcome

**

Please choose one and delete the others

***

Specify the comparison. For example group 1 vs. 3 = −6; group 1 vs. 2 = −8

****

P value for testing the linear trend of the OR/RR across different categories or doses

Number of subjects with outcome

Specify the comparison. For example group 1 vs. 3 = −6; group 1 vs. 2 = −8

P value for testing the linear trend of the OR/RR across different categories or doses

From: Appendix C, Evidence Tables: A-E

Cover of Vitamin D and Calcium
Vitamin D and Calcium: A Systematic Review of Health Outcomes.
Evidence Reports/Technology Assessments, No. 183.
Chung M, Balk EM, Brendel M, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.